H.R. 1632: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025

H.R. 1632 is a federal bill in the 119th Congress. Currently, all drugs, biological products, and medical devices must undergo a full approval process by the U.S. Food and Drug Administration (FDA) before they can be sold in the United States. This bill changes that by creating a new, faster pathway for… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.